• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活物在大鼠实验性微血栓上的定位。显微放射自显影观察。

Localization of tissue plasminogen activator on experimental microthrombi in rats. Microautoradiographic observations.

作者信息

Kimata H, Koide T, Nakajima K, Kondo S

机构信息

Tokyo Research Laboratories, Kowa Co., Ltd., Japan.

出版信息

J Pharmacobiodyn. 1991 Jan;14(1):25-33. doi: 10.1248/bpb1978.14.25.

DOI:10.1248/bpb1978.14.25
PMID:1907322
Abstract

The localization of tissue plasminogen activator (t-PA) on microthrombi in various organs of disseminated intravascular coagulation rats (DIC rats) was investigated by using microautoradiographic technique. After the injection of [125I]fibrinogen, experimental DIC rats induced by the infusion of thrombin for 1 h were submitted to microautoradiograms (MARGMs) of some major organs. The radioactivity of [125I]fibrin thrombi, which were observed as silver grains, was localized in the glomeruli and parts of small vessels in the kidney. In the liver, microthrombi were seen in sinusoid vessels and on Kupffer cells. In addition, many microthrombi were noted in small vessels in the lung and marginal zones in the spleen. Two min after the intravenous administration of [125I]t-PA to DIC rats, many silver grains were observed on each MARGM of the kidney, lung, liver and spleen showing the formation of microthrombi. From the identical results with the observations of MARGMs after the injection of [125I]fibrinogen, we confirmed that t-PA was highly accumulated to microthrombi formed in small vessels of the organs. The scattered silver grains were widely observed on the hepatocytes. This result suggested that t-PA bound to the parenchymal cell surface might be transported into the hepatocytes by receptor-mediated endocytosis. On the other hand, when [125I]urokinase plasminogen activator [( 125I]u-PA) was administered intravenously to DIC rats, many silver grains were observed on MARGM of the proximal tubules in the kidney but not seen on MARGMs of the glomeruli in the kidney, nor in the lung, liver, and spleen. This observation suggested that u-PA might not have a characteristic to accumulate to thrombi.

摘要

采用显微放射自显影技术研究了组织型纤溶酶原激活剂(t-PA)在弥散性血管内凝血大鼠(DIC大鼠)各器官微血栓上的定位。注射[125I]纤维蛋白原后,对经凝血酶输注1小时诱导的实验性DIC大鼠的一些主要器官进行显微放射自显影(MARGMs)。作为银颗粒观察到的[125I]纤维蛋白血栓的放射性定位于肾脏的肾小球和部分小血管中。在肝脏中,微血栓见于窦状血管和库普弗细胞上。此外,在肺的小血管和脾脏的边缘区发现许多微血栓。给DIC大鼠静脉注射[125I]t-PA两分钟后,在肾脏、肺、肝脏和脾脏的每个MARGM上观察到许多银颗粒,表明形成了微血栓。根据注射[125I]纤维蛋白原后MARGMs的观察结果相同,我们证实t-PA高度聚集在器官小血管中形成的微血栓上。在肝细胞上广泛观察到散在的银颗粒。这一结果表明,结合到实质细胞表面的t-PA可能通过受体介导的内吞作用转运到肝细胞中。另一方面,当给DIC大鼠静脉注射[125I]尿激酶型纤溶酶原激活剂[(125I]u-PA)时,在肾脏近端小管的MARGM上观察到许多银颗粒,但在肾脏的肾小球、肺、肝脏和脾脏的MARGM上未观察到。这一观察结果表明,u-PA可能不具有聚集到血栓上的特性。

相似文献

1
Localization of tissue plasminogen activator on experimental microthrombi in rats. Microautoradiographic observations.组织型纤溶酶原激活物在大鼠实验性微血栓上的定位。显微放射自显影观察。
J Pharmacobiodyn. 1991 Jan;14(1):25-33. doi: 10.1248/bpb1978.14.25.
2
Localization of tissue plasminogen activator on experimental thrombi in rats.组织型纤溶酶原激活剂在大鼠实验性血栓上的定位
J Pharmacobiodyn. 1990 Dec;13(12):751-9. doi: 10.1248/bpb1978.13.751.
3
Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.内毒素诱导的兔血管内凝血:组织型纤溶酶原激活物与尿激酶对纤溶酶原激活物抑制物生成、纤维蛋白沉积及死亡率的影响
Thromb Haemost. 1995 Dec;74(6):1578-82.
4
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(u-PA)和K1K2Pu(一种t-PA/u-PA嵌合体)的溶栓特性比较
J Am Coll Cardiol. 1992 May;19(6):1350-9. doi: 10.1016/0735-1097(92)90344-m.
5
Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis.尿激酶、组织型纤溶酶原激活剂及纤溶酶原激活剂抑制剂-1在伴有血栓形成的严重狭窄及闭塞静脉移植物中的表达
Blood Coagul Fibrinolysis. 2003 Jun;14(4):369-77. doi: 10.1097/00001721-200306000-00008.
6
Thrombolytic effect of tissue plasminogen activator in a cerebral embolic model.组织型纤溶酶原激活剂在脑栓塞模型中的溶栓作用。
J Pharmacobiodyn. 1991 Jul;14(7):399-406. doi: 10.1248/bpb1978.14.399.
7
Synergism of thrombolytic agents in vivo.溶栓药物在体内的协同作用。
Circulation. 1986 Oct;74(4):838-42. doi: 10.1161/01.cir.74.4.838.
8
The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.尖吻蝮蛇毒纤溶酶FIIa对兔弥散性血管内凝血的影响
Transl Res. 2007 Nov;150(5):295-302. doi: 10.1016/j.trsl.2007.06.004. Epub 2007 Jul 16.
9
Binding of human tissue plasminogen activator (t-PA) to blood clots and clot-lytic activity of clot-bound t-PA.人组织型纤溶酶原激活剂(t-PA)与血凝块的结合及血凝块结合型t-PA的溶栓活性。
J Pharmacobiodyn. 1990 Dec;13(12):745-50. doi: 10.1248/bpb1978.13.745.
10
[Disseminated intravascular coagulation induced by endotoxin in rabbits: effect of treatment with t-PA and urokinase].[内毒素诱导兔弥散性血管内凝血:组织型纤溶酶原激活物和尿激酶治疗的效果]
Sangre (Barc). 1992 Dec;37(6):435-8.